Regeneron Pharmaceuticals Inc (REGN) reported a profit for first quarter that Drops, from the same period last year
The company's earnings totaled $727.2 million, or $6.75 per share. This compares with $808.7 million, or $7.27 per share, last year.
Excluding items, Regeneron Pharmaceuticals Inc reported adjusted earnings of $1.040 billion or $9.47 per share for the period.
The company's revenue for the period rose 19.0% to $3.605 billion from $3.029 billion last year.
Regeneron Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings: $727.2 Mln. vs. $808.7 Mln. last year.-EPS: $6.75 vs. $7.27 last year.-Revenue: $3.605 Bln vs. $3.029 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.